Outcome of Board Meeting Airan Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. Airan Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
Outcome of Board Meeting Airan Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. Airan Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
Result Audited Financial Results for the quarter and year ended March 31, 2026 are attached herewith. Audited Financial Results for the quarter and year ended March 31, 2026 are attached herewith.
Result Audited Financial Results for the quarter and year ended March 31, 2026 are attached herewith. Audited Financial Results for the quarter and year ended March 31, 2026 are attached herewith.
Corp. Action Board Recommended a final dividend @ 24% i.e. 2.40/- per equity shares of Rs. 10/- each for the financial year 2025-26 subject to the approval of shareholders at the ensuing AGM Board Recommended a final dividend @ 24% i.e. 2.40/- per equity shares of Rs. 10/- each for the financial year 2025-26 subject to the approval of shareholders at the ensuing AGM
Corp. Action Board Recommended a final dividend @ 24% i.e. 2.40/- per equity shares of Rs. 10/- each for the financial year 2025-26 subject to the approval of shareholders at the ensuing AGM Board Recommended a final dividend @ 24% i.e. 2.40/- per equity shares of Rs. 10/- each for the financial year 2025-26 subject to the approval of shareholders at the ensuing AGM
Outcome of Board Meeting Country Condo's Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. Country Condo's Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
Outcome of Board Meeting Country Condo's Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. Country Condo's Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
Result We are pleased to Submit of Audited Standalone and Consolidated Financial Statements of the Company for the Quarter/Financial year ended March 31, 2026 approved by the Board of Directors in its Meeting held on May 30, 2026. We are pleased to Submit of Audited Standalone and Consolidated Financial Statements of the Company for the Quarter/Financial year ended March 31, 2026 approved by the Board of Directors in its Meeting held on May 30, 2026.
Outcome of Board Meeting Health X Platform Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. Health X Platform Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
Result Standalone & Consolidated Financial Results for financial year ended on March 31, 2026 is attached Standalone & Consolidated Financial Results for financial year ended on March 31, 2026 is attached
Result Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, we hereby inform you that the Board of Directors in their meeting held today, i.e. 30th May, 2026 at the Registered Office situated at 2/70, Block- 2, 3rd Floor, WHS, Kirti Nagar, New Delhi-110015, which commenced at 5:00 P.M. and concluded at 5:40 P.M. had, inter-alia, considered and approved as attached business. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Discl
NSE & BSE filings, quarterly results, insider trades, and smart volume alerts — delivered on WhatsApp or Telegram. No separate app to install.
Need more? Pro tracks up to 500 companies with preferential issue alerts.
No credit card required. Connect WhatsApp or Telegram in minutes.